
|Videos|February 24, 2022
How to talk with parents about the recent Pfizer/BioNTech news for the youngest kids
Author(s)Miranda Hester
Editor-in-chief Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses how to help parents who are worried or nervous about the delay in the expansion of the Pfizer/BioNTech vaccine to children aged 6 months to younger than 4 years.
Advertisement
Editor-in-chief Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses how to help parents who are worried or nervous about the delay in the expansion of the Pfizer/BioNTech vaccine to children aged 6 months to younger than 4 years.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Fremanezumab-vfrm (Ajovy) reduces migraine frequency in children, adolescents with episodic migraine
2
HFNC use in bronchiolitis linked to higher childhood asthma risk
3
Andrew Hershey, MD, discusses latest phase 3 results of fremanezumab-vfrm for pediatric episodic migraine
4
ACT-based program reduces stress in parents of children with ASD
5







